Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

TRANSPLANTATION SCIENCE 2019

About Conference


Conference Series LLC LTD invites all the participants from all over the world to attend ‘International Conference on Organ Donation and Transplantation Science' during July 15-16, 2019 Sydney, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Transplantation Science 2019 is the premier event that brings together a unique and international mix of experts, researchers and decision makers both from academia, medical and hospitals across the globe to exchange their knowledge, expertise and research innovations to build world class expert Doctors.

It’s our greatest pleasure to welcome you to the official website of ‘International Conference on Organ Donation and Transplantation Science’ that aims at bringing together the Professors, Researchers, Doctors, and Surgeons to provide an international forum for the dissemination of original research results, new ideas and practical development experiences which concentrate on both theory and practices. The conference will be held in July 15-16, 2019 Sydney ,Australia. The theme of the conference is “Frontiers in Transplantation Science for Promising Future”. Featuring 2-days of scientific workshop, special sessions, speaker & poster session, Industrial Expo. 300+ attendees from all over the world.

The event focuses on aspects such as Organ Transplantation SurgeryHeart Transplant SurgeryLiver TransplantationKidney TransplantationLungs TransplantationGender reassignment Surgery and Transplantation Techniques as well understanding tools to overcome barrier and enable successful data analysis and management. Conference Series LLC Ltd organizes of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

With members from around the world focused on learning about Organ Transplantation and its advances; this is your best opportunity to reach the largest assemblage of participants from the Organ Donation and Transplantation Science community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new advancements and developments, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Organ Transplantation are hallmarks of this conference.

Why Sydney, Australia?
 
Sydney, the capital of New South Wales, Australia is known as the Harbor City. It’s the largest, city with a population of around 4 million. It has an enviable reputation as one of the world’s most beautiful and lies amid a seductive intermingling of land and sea. Sydney is a major global city and one of the most important cities for finance in the Asia-Pacific. Sydney is built around a huge harbor and hosts many tourist attractions as well as a number of beaches, bays and a couple of national parks. Brimming with history, nature, culture, art, fashion, cuisine, design, Sydney’s set next to miles of ocean coastline and sandy surf beaches. Long-term immigration has led to the city’s reputation as one of the most culturally and ethnically diverse cities in Australia and the world. The city is also home to the Sydney Opera House and the Sydney Harbor Bridge, two of the most iconic structures on this planet. Sydney’s 4,757,083 residents sprawl over an area of more than 12,350km². Sydney was the site of the first British colony in Australia, which was set up in 1788. The general area classified under Sydney is actually broken up into 38 separate governmental districts over an area of around 1687 square kilometers. Sydney was originally going to be named “Albion”, but its founder, Arthur Phillip, changed the name in recognition of Thomas Townshend Lord Sydney’s efforts in authorizing the colony’s establishment. Sydney annually ranks among worldwide Top Ten Most Liveable Cities lists
 
Thankfully, Air travelers won’t need to go out of their way to experience the multitude of shopping, dining and entertainment experiences on offer at the Airport’s.
 
Target Audience:
  • Heart surgeons
  • Scientists
  • Researchers
  • Expert Surgeons
  • Doctors
  • Dermatologists
  • Organ Transplantation Associations
  • Organ Transplantation Societies
  • Business Entrepreneurs
  • Training Institutes
  •  Hospitals
  • Manufacturing Medical Devices Companies

 For more information: https://world.geneticconferences.com/

 

Sessions/Tracks

Sessions/Tracks

Track 1 Organ Transplantation Surgery:

Organ Transplantation Surgery is a beneficial technique in which a section of tissue or a complete organ that is removed from its original natural site and transferred to a new position in the same person or in a separate individual. The donated organ may be from a deceased donor, a living donor. In some cases an artificial organ are also used.

WHO Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)

Track 2 Organ Donations:

Organ donation is an act of giving one or more organs without compensation for transplantation into someone else. Organ donation is a very personal yet complex decision, intertwined with medical, legal, religious, cultural, and ethical issues. Donations include the liver, kidney, pancreas, and heart.

International Society for Organ Donation and Procurement (ISODP), International Transplant Nurses Society (ITNS), Transplantation Society of Australia and New Zealand, Australia: Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation

Track 3 Liver Transplantation:

Liver transplant is a surgical procedure to remove a diseased liver and replace it with a healthy liver from a donor. Most liver transplant operations use livers from deceased donors, though a liver may also come from a living donor. The liver has sizable reserves and a great capacity to regenerate itself. Often, symptoms aren't evident until significant damage has been done. At present, there is no known way to medically compensate for the loss of a liver.

Saudi Centre for Organ TransplantationMiddle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant CenterEuropean Society of TransplantationBelgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO), Greece: Hellenic National Transplant Organization

Track 4 Kidney Transplantation:

Kidney transplant is a treatment for persons who have chronic renal failure requiring dialysis. Kidney transplants are among the most commonly performed types of transplant surgery. Kidneys often are donated from living relatives to ensure the greatest prospects of long-term survival and today, more than four-fifths of patients with transplanted kidneys will survive for more than five years.

Hellenic National Transplant Organization, Italy: Centro National Trapianti (CNT), Poland: Poltransplant, Spain: Organization National de Transplants (ONT)

Track 5 Heart Transplantation:

Heart transplantation is the replacement of a patient's diseased or injured heart with a healthy donor heart. Heart Transplantation is a treatment option for people who are in the end stages of heart failure. Heart transplant surgery lasts for approximately four hours. During that time, you’ll be placed on a heart-lung machine to keep blood circulating throughout your body.

European Society of TransplantationBelgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO), Greece: Hellenic National Transplant Organization

Track 6 Robotics Transplantation:

Robotic Transplantation is a robot-assisted surgery that aids surgeons in executing the most complex operations with extreme accuracy, mobility, and control as compared to the traditional procedures. The most widely used clinical robotic surgical system includes a camera arm and mechanical arms with surgical instruments attached to them. The surgeon controls the arms while seated at a computer console near the operating table. The console gives the surgeon a high-definition, magnified, 3-D view of the surgical site.

Saudi Centre for Organ TransplantationMiddle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant CenterEuropean Society of TransplantationBelgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO)

Track 7 Medical Device Industry:

The Medical device industry makes an enormous number of products ranging from surgical gloves to artificial joints to imaging equipment and plays a crucial role in developing new medical technologies that can improve the ability to diagnose and treat illness. The industry has a relatively small number of large, diversified companies and a large number of smaller companies that are mainly engaged in research and development of new devices for specific therapeutic areas. The industry is distinctive both for its tendencies to make frequent, incremental changes to its products and its extensive ties with physicians.

Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, MalaysiaMalaysia Society of Transplantation, Singapore: National Organ Transplant Unit, Saudi Arabia: Saudi Centre for Organ TransplantationMiddle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant CenterEuropean Society of Transplantation

Track 8 Gender Reassignment Surgery:

Gender reassignment surgery sometimes called Sex reassignment surgeryis implemented to transition individuals with gender dysphonia to their desired gender. Gender reassignment is irrelevant to a person’s ability to perform a job. Indeed, having previously had to live with the pressure of gender dysphonia, a transsexual person who has completed a change of gender identity is likely to emerge a better worker than before.

Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)

Track 9 Transplantation Techniques:

In Transplantation technique a complete organ that is removed from its original natural site and transferred to a new position in the same person or in a separate individual. The term, like the synonym graft, was borrowed from horticulture. Both words imply that success will result in a healthy and flourishing graft or transplant, which will gain its nourishment from its new environment.

International Society for Organ Donation and Procurement (ISODP), International Transplant Nurses Society (ITNS), Transplantation Society of Australia and New Zealand, Australia: Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation

Track 10 Bone Marrow transplantation:

bone marrow transplant involves taking cells that are normally found in the bone marrow, filtering those cells, and giving them back either to the patient they were taken from or to another person. The goal of BMT is to transfuse healthy bone marrow cells into a person after his or her own unhealthy bone marrow has been eliminated.

Saudi Centre for Organ TransplantationMiddle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of TransplantationBelgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO)

Track 11 Burn Repair Surgery:

This involves the removal of healthy skin tissues from one part of the body and transplanting it to the burn site. This skin graft may include only a few outer layers of skin or may involve the entire dermis. This is used in cases of severe burns where a large section of the dermis is affected. This procedure has many advantages as the skin colour and texture are a near perfect match thus reducing scarring to a large extent.

Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation, Singapore: National Organ Transplant Unit, Saudi Arabia: Saudi Centre for Organ TransplantationMiddle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant CenterEuropean Society of Transplantation

Track 12 Bridges for Transplantation:

A generic term for any organ or surrogate device used to stabilize a patient before definitive transplantation of a matched organ.

Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)

Track 13 Transplant Rejections:

Transplant Rejection happens when a person receives an organ from someone else during transplant surgery, that person's immune system may recognize that it is foreign. This is because the person's immune system detects that the antigens on the cells of the organ are different or not "matched." Mismatched organs, or organs that are not matched closely enough, can trigger a blood transfusion reaction or transplant rejection.

International Society for Organ Donation and Procurement (ISODP), International Transplant Nurses Society (ITNS), Transplantation Society of Australia and New Zealand, Australia: Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation

Track 14 Organ Transport Systems:

In Organ transport system the organs are placed in sterile containers, packaged in wet ice, and transported to the recipient's transplant center. Hearts and lungs must be transplanted within approximately four hours after being removed from the donor in transport system.

Hellenic National Transplant Organization, Italy: Centro Nazionale Trapianti (CNT), Netherlands: Nederlandse Transplantatie Vereniging, Spain: Organization National de Transplants (ONT)

Track 15 Commercialization of Organs:

Commercialization of Organs in itself cannot be held as immoral. The  premier  and  essential  objection  to  the  sale  of  human  body  parts  on secular grounds is that commercialization would tend unavoidably to harm sellers.  More  specifically,  the  basic  concern  here  is  that  due  to  the  sup-posed inevitability of exploitation and coercion, the sale of human body parts cannot be contained in a just health care system. We will address this core  secular  argument  in  terms  of  its  two  separable,  primary  elements: exploitation and coercion.

Saudi Centre for Organ TransplantationMiddle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of TransplantationBelgian Transplantation Society, Denmark: Dansk Transplantationsselskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO)

Track 16 Legal and Ethical aspects:

The legislation called the Transplantation of Human Organ Act (THO) was passed in 1994 to streamline organ donation and transplantation activities. Broadly, the act accepted brain death as a form of death and made the sale of organs a punishable offence. With the acceptance of brain death, it became possible to not only undertake kidney transplantations but also start other solid organ transplants like liver, heart, lungs, and pancreas. Parallel to the living related and unrelated donation program, the deceased donation program has slowly evolved. In approximately one-third of all liver transplants, the organs have come from the deceased donor program as have all the hearts and pancreas transplants. In these states, a few hospitals along with committed NGOs have kept the momentum of the deceased donor program.

To overcome organ shortage, developed countries are re-looking at the ethics of unrelated programs and there seems to be a move towards making this an acceptable legal alternative. The ethics of commerce in organ donation and transplant tourism has been widely criticized by international bodies. The legal and ethical principles that we follow universally with organ donation and transplantation are also important for the future as these may be used to resolve our conflicts related to emerging sciences such as cloning, tissue engineering, and stem cells

Ethics of organ sale

The presence of a growing middle class, the lack of a national health insurance scheme, the growing disparity between the rich and poor, and to some extent the presence of technology makes the process of commodification of organs a simple, quick, and attractive business proposition for some and a solution for others. The more recent live liver donation program has also been influenced by kidney donation and unrelated living donations have been reported in the media including two deaths. Although kidney donation is a relatively safe surgery, the rising incidence of diabetes and hypertension in India makes the young donors potentially risk their health in the long-term. In some of the studies, it has been noted that when the motive of donation has been purely commercial, donors in the post-operative period have been more prone to ill-health. Whereas when the donation was purely altruistic, there was the feel-good factor and the psychological recovery was much better.

Track 17 Socioeconomic factors:

Socioeconomic factors have been shown to affect health care outcomes. Poverty, unemployment, and low education level have been listed among the factors that adversely affect health.

 Transplantation noncompliance: occupational status, educational level, language or cultural barriers, and ethnic background.  Race and income have substantial effects on mortality and use of services among Medicare beneficiaries.  Poor individuals are less likely than wealthy individuals to be medically suitable, to be interested in transplantation, and to complete the pre- transplantation workup

Based on UNOS data, in patients with liver transplant, it has been shown that neighbourhood income had no effect on graft or patient survival, education had only marginal influence on the outcome (survival was lower in those with a high school education than in those with graduate education), and patients with Medicaid and Medicare had lower survival when compared with those with private insurance .The results of our study that was done in kidney transplant recipients are similar. In the entire patient group, there is a statistically significant benefit to graft and patient survival from having private insurance compared with Medicare. This effect was observed across almost all racial groups (except for Asian patients, for whom there was no significant association between private insurance and graft survival). HMO/PPO was associated with significantly higher risk for graft failure but improved patient survival. These results are similar to those reported in liver transplant recipients. 

 

Market Analysis

Importance and scope:
 
Organ transplantations save lives in patients affected by terminal organ failures and improve quality of life. Organ transplantations have gradually ameliorated in the last two decades and usually provide excellent results in children and young adults, and are increasingly challenged by the growing proportion of elderly transplant patients with comorbidities. Renal transplantation increases patient survival over dialysis, and lifesaving transplants are indispensable to treat patients with liver, heart, or lung irreversible diseases. Organ transplant programs activity has been steadily growing but is still far from global needs, with great differences among countries. Solid organ transplantations are essential for developed and mature health care systems. The factors driving this market include the advancements made in tissue engineering and organ transplantations. These transplantations help in survival of many patients as well as enhance the quality of life. The lack of availability of organs and high cost of transplantation are the limitations for the growth of this market. The increase in use of tissue engineering for generation of implants provides growth opportunity to this market.
 
Organ transplant immunosuppressant drugs market has accelerated the growth of rapid organ transplant by reducing the harmful side effects such as autoimmune diseases. These novel drug therapies are strategically analyzed in the report in order to provide comparative benefits. The report is also focusing on the regulatory issues and commercial mandate that are hindering the growth. Porter’s five forces model is strategically analyzed in the report to project current and future market scenarios. The value chain analysis of the organ transplant immunosuppressant drugs market is dealt strategically. Top wining strategies adopted by the key players competing in this market are critically analyzed through primaries.
 
Value of Organ Transplantation in Society:
 
Transplantation in number of procedures. The global and regional markets for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments - Organ Transplantation (Heart, Kidneys, Liver, Pancreas, and Lungs). The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
 
At least 79,950 kidney transplants done in 2014.
 
*Kidney transplants are done in 99 countries.
 
* 27,397 donations were reported from dead persons in 2014. Currently there are 77 countries worldwide with deceased donation programmes
 
* About 119,900 solid organs were transplanted worldwide in 2014, an increase of 1.8 per cent since 2013
 
*26,150 liver transplants were done worldwide in 2014. Liver transplants are performed in 74 countries
 
* 119,873 organs transplanted annually (2014)
 
* 27,397 actual deceased organ donors in 2014
 
* 13.6 transplants per hour done in 2014
 
* In 2012, the UAE did 19 kidney transplants from living donors and 28 in 2013 - Data from Global Observatory on Donation and Transplantation.
 
The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immune suppressants, and organ preservation solutions is a major factor anticipated to boost growth of the market during forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for management of organ failure. Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives. The organ and tissue transplantation market in the U.S. is estimated at $11.7 billion in 2005 and is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010.The transplantation market is estimated at just under $5 billion in 2005 and is expanding at an AAGR of 4.8%.The fastest growing sector is small bowel (intestine) transplantation. Kidney and liver transplantation will account for 78% of the total in 2005.The U.S. tissue transplantation market totaled about $6.8 billion in 2005. It is projected to grow at an AAGR of 5.5%, to $8.9 billion in 2010.
 

Donor rates in Australia

Australian donor rates are on the rise. Between 2009 and 2013, donor numbers increased by 29%. In 2009 there were 11.4 donors per million of the population. By 2013 there were 16.9 donors per million of the population. In Australia around 1600 people are on the organ transplant waiting list at any time. Less than 1% of persons whose death is in hospital can be potential donors because of the limited circumstances for which organ donation is possible. In 2013 only 40% of patients on the organ wait list received a transplant and 2% of the patients on the waiting list died while waiting for an organ.

 Donor rates in Australia per million population.

Year

Organ donors

per million population

Organ transplant recipients

per million population

Organs transplanted

per million population

2009

11.4

37.2

39.5

2010

14

42.8

45.1

2011

15.1

45.2

47.3

2012

15.6

46.3

48.8

2013

16.9

48.5

50.9

Table 1.3 source: Australian Government Organ and Tissue Donation and Transplantation Authority (2014). Annual Report.

 Transplanted organs 2014 in Australia

Organ

Number

Kidneys

659

Livers

237

Hearts

79

Heart/Lungs

4

Lungs

159

Pancreas (including pancreas islets)

54

Total

1,193

 Australian Government Organ and Tissue and Transplantation Authority (2014). Facts and Statistics.

Australian Organ Donor Register

The Australian Organ Donor Register is a government register. People can register to be organ donors or they can register that they wish to not be an organ donor. The register is nationwide and is the only register in Australia. Registering is simple and can be done online at the Donate life.

 
Why to attend???
 
The significance of human life and organs. Organ Transplantation is essential for us. Heart, Kidney, Liver, pancreas, and so many organs are Trans planted. This conference seek to bring all such Cardiologists, Therapists, Surgeons, Healthcare Agencies, Healthcare Professionals, Doctors, Registered Nurses and researcher or scientist, Noble Laureate, researcher, research scholar, students and people together who are involved in this field and provide them to discuss about their innovation, exchange ideas and interaction with each other.
 
Major Organ Donation Societies around the Globe:
 
WHO Global Observatory on Donation and Transplantation (GODT)
 
Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT)
 
Donation and Transplantation Institute (DTI)
 
International Society for Heart and Lung Transplantation (ISHLT)
 
International Society for Organ Donation and Procurement (ISODP)
 
International Transplant Nurses Society (ITNS)
 
Transplantation Society of Australia and New Zealand
 
Australia: Organ and Tissue Authority
 
Philippines: National Kidney and Transplant institute
 
Japan: Japan Organ Transplant Network
 
Malaysia: Malaysia Society of Transplantation
 
Singapore: National Organ Transplant Unit
 
Saudi Arabia: Saudi Centre for Organ Transplantation
 
Middle East Society for Organ Transplantation (MESOT)
 
Israel: ADI - National Transplant Center
 
European Society of Transplantation
 
Belgian Transplantation Society
 
Denmark: Dansk Transplantationsselskab
 
France: French Federation for Organ Donation
 
Germany: Deutsche Stiftung Organtransplantation (DSO)
 
Greece: Hellenic National Transplant Organization
 
Italy: Centro Nazionale Trapianti (CNT)
 
Netherlands: Nederlandse Transplantatie Vereniging
 
Poland: Poltransplant
 
Spain: Organización Nacional de Trasplantes (ONT)
 
United Kingdom: National Health Service Blood and Transplant
 
Brazil: Coordenaçao -Geral do Sistema Nacional de Transplantes
 
Mexico: Centro Nacional de Trasplantes (CENATRA)
 
Canadian Blood Services – Organ and Tissue Donation and Transplantation
 
American Society of Transplantation (AST)
 
Description: https://d2cax41o7ahm5l.cloudfront.net/cs/upload-images/organtransplantation2018-38818.png
 
Target Audience:
 
The target audience will be Cardiologists, Therapists, Surgeons, Healthcare Agencies, Healthcare Professionals, Doctors, Registered Nurses and researcher or scientist who are researching in Organ Donation and Transplantation Science.
 
Meet Your Target Market:
 
With members from around the world focused on learning about Surgeons, this is your single best opportunity to reach the largest assemblage of participants from the all Over the World. Conduct demonstrations, distribute information, meet with current, make a splash with a new product line, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Organ Donation and Transplantation Science are hallmarks of this conference.
 

 

Past Conference Report

Organ transplantation 2018 Report

World congress on Organ transplantation and artificial Organs was hosted by the Conference Series LLC LTD at Tokyo, Japan during August 24-25, 2017 with the theme “Explore and Exploit the Novel Techniques to Repair, Restore and Regenerate”.

The conference marked its start by an opening ceremony which included introduction by the Honourable Guests and the Members of Keynote Forum. All the speakers have extended their contribution in the form of highly informative presentations to lead the conference to the ladder of success.

Conference Series extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.

We would like to specially thank the following people who laid the foundation for the event’s success

Organizing Committee Members:

  • Medhat Askar- Director, Transplant ommunology, Baylor university,USA
  • Walter G.Land- professor, University of stasbourg, France
  • Elmar jaeckel- Professor, Hannover Medical School, Germany
  • Matteo Ravaioli- Doctor, University of bologna, Italy
  • Janez Rozman- Doctor, University of Ljubljana, solvenia
  • Edyta Skwirczynska- Associate Professor,  Pomeranian medical university, poland
  • Fariborz Tavangarian-Associate Professor, Pennsylvania state University, USA

Keynote Speakers:

  • Bruce Geleb- NYU Langone Transplant Institute, USA
  • Chris Elliott- Leman Micro Devices SA, Switzerland
  • Sujata Malik- Sunburst Healthcare Pvt. Ltd., India
  • Masahiro Onuma- TriSGuide Ltd, Japan
  • Mditsheni J Ramakuela- University of Venda, South Africa
  • Yoshiaki Omura- International College of Acupuncture & Electro-Therapeutics, USA
  • Hiroshi Ohrui- Yokohama University of Pharmacy, Japan

After the huge optimistic response from scientific fraternity, renowned personalities and the Editorial Board Members of Conference Series LLC LTD Group from across the world we are pleased to announce the 8th International Conference on Organ donation and transplantation to be held during July 15-16, 2019 at Sydney, Australia.

Let us meet again @ Transplantation science 2019

To Collaborate Scientific Professionals around the World

Conference Date July 15-16, 2019

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Transplantation Technologies & Research Journal of Clinical and Experimental Transplantation Medical Safety & Global Health

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by